Funds holding Staidson Beijing Biopharmaceuticals Co Ltd
ISIN CNE100001237 · China
- Fund holders
- 5
- Of which ETFs
- 1 4 other funds
- Value held
- 3.8M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 474,719 | 1.5M $ | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 473,500 | 1.5M $ | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 184,900 | 602.4K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 27,000 | 88K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD ESG INTERNATIONAL STOCK ETF VANGUARD WORLD FUND | 13,500 | 51.4K $ | 0.00 % | as of May 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD ESG INTERNATIONAL STOCK ETF VANGUARD WORLD FUND | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 0.00 % | as of Jul 31, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 5 | +2 | 1,173,619 | +9.2 % |
| 2026Q2 | 3 | +2 | 1,074,719 | +126.4 % |
| 2026Q1 | 1 | 0 | 474,719 | 0.0 % |
| 2025Q4 | 1 | 0 | 474,719 | 0.0 % |
| 2025Q3 | 1 | 0 | 474,719 | 0.0 % |
| 2025Q2 | 1 | 0 | 474,719 | 0.0 % |
| 2025Q1 | 1 | 0 | 474,719 | 0.0 % |
| 2024Q4 | 1 | -1 | 474,719 | -2.2 % |
| 2024Q3 | 2 | -2 | 485,219 | -60.7 % |
| 2024Q2 | 4 | +3 | 1,233,419 | +1,219.2 % |
| 2024Q1 | 1 | -3 | 93,500 | -89.4 % |
| 2023Q4 | 4 | 886,119 |
Cite this page
Titelia. "Funds holding Staidson Beijing Biopharmaceuticals Co Ltd". https://titelia.com/en/stocks/staidson-beijing-biopharmaceuticals-co-ltd-CNE100001237